TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 88 filers reported holding TANGO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,057,663 | +233.1% | 3,557,519 | -1.8% | 0.00% | – |
Q2 2023 | $12,026,619 | -14.0% | 3,622,476 | +2.4% | 0.00% | – |
Q1 2023 | $13,978,703 | -45.7% | 3,538,912 | -0.3% | 0.00% | -100.0% |
Q4 2022 | $25,745,992 | +143.6% | 3,551,171 | +21.6% | 0.00% | – |
Q3 2022 | $10,571,000 | -26.2% | 2,920,410 | -7.6% | 0.00% | – |
Q2 2022 | $14,316,000 | +26.5% | 3,160,387 | +111.7% | 0.00% | – |
Q1 2022 | $11,319,000 | -10.2% | 1,493,186 | +29.6% | 0.00% | – |
Q4 2021 | $12,607,000 | -30.0% | 1,152,440 | -17.3% | 0.00% | -100.0% |
Q3 2021 | $18,014,000 | – | 1,393,168 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |